Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

NCT01377597 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion

Interventions

DRUG: ranibizumab

Sponsor

Novartis Pharmaceuticals